pc12 cell line (ATCC)
Structured Review
Pc12 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 4408 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pc12+cell+line/PC-12/pm42218217-53-1-8
Average 98 stars, based on 4408 article reviews
Images
Related Articles
Derivative Assay:Article Title: Optimizing scaffold properties for nerve regeneration: Effects of bioactive glass in 3D-printed chitosan structures. Article Snippet: Peripheral nerve injuries remain a challenge for regenerative medicine and, when not properly healed, yield significant consequences for the patient, such as functional loss and neuropathic pain.. Despite the intrinsic repair capacity of these structures, the process is limited to mild injuries and may not result in functional recovery.. The gold standard in this field is the use of autologous grafts; however, this method has several disadvantages, including donor tissue morbidity and a low functional recovery rate. Article Title: Potential Antioxidant and Neuroprotective Effect of Polysaccharide Isolated from Digüeñe Cyttaria espinosae Article Snippet: .. PC12 Cells The Article Title: Self-assembled carrier-free nanoplatforms for sequential modulation of the oxidative-inflammatory cascade in cerebral ischemia-reperfusion injury Article Snippet: Cerebral ischemia-reperfusion injury (CIRI) poses a major challenge in managing ischemic stroke.. The excessive reactive oxygen species (ROS) and amplified inflammatory/immune responses are the pivotal factors exacerbating neuronal death after ischemic stroke, rendering the dual regulation of oxidative stress and inflammatory responses a key therapeutic target.. Here, we engineered a brain-targeted nanotherapeutic via molecular interaction-driven self-assembly, achieving high efficiency co-loading of baicalein and celastrol for synergistic oxidative stress-inflammation interception in CIRI. CCK-8 Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Membrane:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Iron Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Enzyme-linked Immunosorbent Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Saline:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Isolation:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. GSSG Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Lysis:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Multiple Displacement Amplification:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Activity Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Bicinchoninic Acid Protein Assay:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Bioprocessing:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Recombinant:Article Title: Shikonin attenuates diabetic Parkinsonian neuronal injury by facilitating p53/SLC25A28-mediated iron shuttling. Article Snippet: Diabetes significantly increases the risk of Parkinson’s disease (PD), and mitochondrial dysfunction is considered a shared pathological mechanism between diabetes and PD.. Although our previous research indicated that shikonin ameliorates hyperglycemia-driven PD progression through dual regulation of glycolysis (via inhibition of pyruvate kinase muscle isozyme 2) and mitochondrial function, its mitochondrial repair mechanism remains unclear.. Here, we demonstrate that shikonin repairs neuronal damage induced by high glucose and 6-hydroxydopamine via a PKM2-independent, p53/Solute Carrier Family 25 Member 28 (SLC25A28)-dependent mitochondrial iron shuttle. Marker:Article Title: Artificial expression constructs for selectively modulating gene expression in interneurons Article Snippet: .. The Cell Culture:Article Title: PKM2-driven glycolysis mediates rotenone neurotoxicity via MG-Hs in Parkinson's disease. Article Snippet: .. The Article Title: Potential Antioxidant and Neuroprotective Effect of Polysaccharide Isolated from Digüeñe Cyttaria espinosae Article Snippet: .. PC12 Cells The Article Title: Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy. Article Snippet: .. The Modification:Article Title: Potential Antioxidant and Neuroprotective Effect of Polysaccharide Isolated from Digüeñe Cyttaria espinosae Article Snippet: .. PC12 Cells The |

![( A and B ) The cross-talk between L- and D-Aβ42 isomers potently suppresses neurotoxicity. While individual stereoisomers are toxic to neuronal <t>PC12</t> cells (A), coincubation of all-L Aβ42 with its D-isomers in a 1:1 mixture substantially rescues cell viability, with the dD/L and dSdD/L mixtures restoring viability to near-control levels (B). The 95% confidence interval of median inhibitory concentration (IC 50 ): All-L: [17.97, 22.07]; dS: [8.591, 10.47]; dD: [21.00, 27.01]; dSdD: [38.71, 59.87]. Error bars showing the SD ( n = 5, biological replicates). (** P < 0.01 and **** P < 0.0001). ( C to E ) Quantitative proteomics reveals the molecular basis for this rescue. A four-quadrant volcano plot analysis was used to specifically isolate proteins whose expression is uniquely altered by the cross-talk effect, distinguishing them from proteins affected by the individual isomers alone. ( F and G ) Identified GO and KEGG pathways for the up-regulated (F) and down-regulated (G) proteins in STEP or cross-talk group compared with L. EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; GTPases, guanosine triphosphatases. ( H ) A protein-protein interaction (PPI) network for the LD group highlights a core hub of ribosomal proteins, directly implicating the restoration of protein synthesis as a key mechanism underlying the neuroprotective effect of stereochemical cross-talk.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5051/pmc13025051/pmc13025051__sciadv.aeb2729-f5.jpg)